Workshop: Recent Advances in Oral Peptide Delivery – From Molecule to Market
An Oral Macrocycle to Access Intracellular RAS Targets in Cancer: The Road to Formulation Design of LUNA18 for Phase I Trials
Monday, July 14, 2025
2:30 PM - 3:00 PM EDT
Location: 123
Sponsored By
LUNA18 is an orally administrable cyclic peptide molecule created by Chugai's unique mid-size molecule drug discovery platform. In this presentation, we will introduce the formulation design of LUNA18, including the challenges encountered during development, our approaches to address these challenges, and the design of our clinical formulation.
.png)
.png)
.png)
